Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 36 for “"Heart--Hypertrophy"”.
-
Mechanistic insights into copper-induced regression of heart hypertrophy.
… relevant levels reverses cardiac myocyte hypertrophy induced by phenylephrine (PE), and that this effect was VEGF-dependent. Yet, the amount of VEGF in the media was unchanged. However, we observed that Cu caused an increase in the ratio of VEGFR-1:VEGFR-2 as well as an increase in PKG-1 …
-
Monocrotaline toxicity and pulmonary arteries
… develop pulmonary hypertension and right heart hypertrophy in the weeks following administration of the chemical. Lung weight increases and right heart hypertrophy correlate with increased pulmonary artery pressure. Rats which consumed monocrotaline drinking water (20 mg/l) for only 4 days …
-
Effects Of Dimethylarginine Dimethylaminohydrolase 1 And Adenosine Monophosphate-Activated Protein Kinase Alpha 2 Gene Deletion On Pulmonary Hypertension In Mice
… mechanism of the development of PAH and right heart hypertrophy/failure. The dissertation has been divided into 2 chapters. The first chapter is determining effect of DDAH1 gene deletion on hypoxia+SU5416-induced pulmonary arterial hypertension and the second chapter is determining effect of …
-
Myocardial oxidative stress changes during compensated rig t heart failure in rats
14-34% of heart failure cases are due to an impairment of the right ventricular function and nothing is known about oxidative stress changes in this condition. In order to address this problem, oxidative stress changes were examined in the right ventricle of rats administered monocrotaline (50 …
-
Analysis of the expression regulation of the human atrial myosin light chain 1 upon hypertrophic stimulation
… in the ventricle of the normal adult human heart. However, ALC-1 is reexpressed in the hypertrophied ventricle of patients with different cardiac diseases. Several in vitro studies as well as transgenic animal models have shown that ALC-1 overexpression leads to an increased cardiac …
-
TOXICOLOGY OF THE PULMONARY ENDOTHELIUM
… by the pulmonary endothelium, and right heart hypertrophy. Preceeding the hypertrophy is a doubling of the mass of the lung and right ventricle. The change in mass of the lung preceeds that of the right ventricle. The increases in both organs is characterized by elevated RNA but not DNA. …
-
MOLECULAR MECHANISMS REGULATING COPPER BALANCE IN HUMAN CELLS
… Loss of copper homeostasis is associated with heart hypertrophy, liver failure, neuronal de-myelination and other pathologies. The copper-transporting ATPases ATP7A and ATP7B maintain cellular copper homeostasis. In response to copper elevation, they traffic from the trans-Golgi network (TGN) …
-
The cellular and molecular mechanisms of oxidant-induced cardiomyocyte hypertrophy
Cardiac hypertrophy is a common consequence of many cardiovascular diseases. It is often a transition to heart failure. Although oxidants have been indicated to mediate heart failure, whether they induce hypertrophy and how they are able to induce hypertrophy are still unknown. The objective of …
-
Ang II-Induced Cardiac Remodeling: Role of PI3-Kinase-Dependent Autophagy
Heart failure (HF) is a pathological state indicating insufficient blood supply to the peripheral tissues from the heart. The pathophysiology of HF is multifactorial like cardiac remodeling including cardiac hypertrophy, perivascular fibrosis and apoptosis to compensate for the heart’s inability to …
-
Calcineurin bei humaner Herzhypertrophie
Calcineurin bei humaner Herzhypertrophie
-
Σχεδιασμός, σύνθεση και αποτίμηση της βιολογικής δράσης νέων ετεροκυκλικών ενώσεων που επάγουν τη δράση της διαλυτής γουανυλικής κυκλάσης
… leading to hypertension, inflammation, heart hypertrophy and heart failure. In addition, this axis maintains homeostasis in other systems and its dysregulation can lead to e.g. fibrosis in multiple organs or altered metabolic (adipose) function. During the last decades, two classes of …
-
Sarcomere positive and negative hypertrophic cardiomyopathy – two distinct pathophysiological entities?
… characterised by unexplained left ventricular hypertrophy and significant clinical heterogeneity. In approximately 40% of patients, it is caused by pathogenic sarcomeric gene variants (Sarc+ HCM) which are associated with a greater risk of ventricular arrhythmia, sudden cardiac death and heart …
-
PHARMACOLOGICAL ASPECTS OF CARDIAC HYPERTROPHY
… been implicated in the regulation of cardiac hypertrophy. The serial injection of a catecholamine (epinephrine, norepinephrine or isoproterenol) will increase cardiac muscle mass. In a canine model of left ventricular hypertrophy secondary to aortic coarctation, the endogen
-
ESTUDIO DE LA RUTA CELULAR JAK2/STAT3 COMO POTENCIAL INHIBIDOR EN EL MODELO DE FIBROSIS PULMONAR
… reversing vascular remodeling and right heart hypertrophy. Masson trichrome stain revealed a reduction of the collagen deposits. Ashcroft score, used to determine the severity of pulmonary fibrosis, was measured and diminished significantly in the CuI treated group. The results showed a …
-
The expression and function of stretch-activated 2P-4TMD K⁺ channels in the heart.
… Acid-stimulated K+ channel; KCNK4) in human heart; the localization of TREK-1 and variants of TREK-2 on the membrane and in cytoplasmic areas of human cardiomyocyte; the notably high-level expression of TREK-1 in diseased human heart; the reverse expression of variant A and C of TREK-2 in …
-
Ion channel determinants of cardiac hypertrophy and cardiomyopathy
… in the progression of pressure-overload cardiac hypertrophy. Results show that the absence of TRPV1 in vivo is protective against cardiac hypertrophy under conditions of pressure overload (Chapter 2); however, in the absence of CRACM1 the pathology is exacerbated (Chapter 3). Further, mice …
-
Development of finite element modeling framework to investigate cardiac hypertrophy in heart diseases
Heart is a prime organ in the human body, and continuously adapting and evolving through growth and remodeling processes to maintain a balance between the demand and supply of blood and oxygen during physiological/developmental (i.e., from birth to adult) and pathological (i.e., various heart …
-
REGULATION OF MYOCARDIAL HYPERTROPHY BY EPINEPHRINE (HEART)
… propranolol, blocked the usual myocardial hypertrophy that occurs in response to hemodynamic overload. These studies strongly implicate β-adrenoceptors in the regulation of myocardial mass. Theoretically, a circulating myocardial trophic hormone should result in biventricular hypertrophy. …
-
The role and mechanisms of hexokinase-2-mediated protection against cardiac cell death and disease
… cardiac HK2 overexpression limits cardiomyocyte hypertrophy and cell death in response to chronic isoproterenol administration in vivo. Results from these studies demonstrate that HK2 limits ROS accumulation during cardiac hypertrophy, and that this attenuation of ROS is mediated via the …
Page 1 of 2